Jennifer S Ford1, Joanne F Chou2, Charles A Sklar2, Kevin C Oeffinger2, Danielle Novetsky Friedman2, Mary McCabe2, Leslie L Robison2, Ruth A Kleinerman2, Yuelin Li2, Brian P Marr2, David H Abramson2, Ira J Dunkel2. 1. Jennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD. fordj@mskcc.org. 2. Jennifer S. Ford, Joanne F. Chou, Charles A. Sklar, Kevin C. Oeffinger, Danielle Novetsky Friedman, Mary McCabe, Yuelin Li, Brian P. Marr, David H. Abramson, and Ira J. Dunkel, Memorial Sloan Kettering Cancer Center; Jennifer S. Ford, Charles A. Sklar, David H. Abramson, and Ira J. Dunkel, Weill-Cornell Medical College, New York, NY; Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; and Ruth A. Kleinerman, National Cancer Institute, Bethesda, MD.
Abstract
PURPOSE: Survival rates for individuals diagnosed with retinoblastoma (RB) exceed 95% in the United States; however, little is known about the long-term psychosocial outcomes of these survivors. PATIENTS AND METHODS: Adult RB survivors, diagnosed from 1932 to 1994 and treated in New York, completed a comprehensive questionnaire adapted from the Childhood Cancer Survivor Study (CCSS), by mail or telephone. Psychosocial outcomes included psychological distress, anxiety, depression, somatization, fear of cancer recurrence, satisfaction with facial appearance, post-traumatic growth, and post-traumatic stress symptoms; noncancer CCSS siblings served as a comparison group. RESULTS: A total of 470 RB survivors (53.6% with bilateral RB; 52.1% female) and 2,820 CCSS siblings were 43.3 (standard deviation [SD], 11) years and 33.2 (SD, 8.4) years old at the time of study, respectively. After adjusting for sociodemographic factors, RB survivors did not have significantly higher rates of depression, somatization, distress, or anxiety compared with CCSS siblings. Although RB survivors were more likely to report post-traumatic stress symptoms of avoidance and/or hyperarousal (both P < .01), only five (1.1%) of 470 met criteria for post-traumatic stress disorder. Among survivors, having a chronic medical condition did not increase the likelihood of psychological problems. Bilateral RB survivors were more likely than unilateral RB survivors to experience fears of cancer recurrence (P < .01) and worry about their children being diagnosed with RB (P < .01). However, bilateral RB survivors were no more likely to report depression, anxiety, or somatic complaints than unilateral survivors. CONCLUSION: Most RB survivors do not have poorer psychosocial functioning compared with a noncancer sample. In addition, bilateral and unilateral RB survivors seem similar with respect to their psychological symptoms.
PURPOSE: Survival rates for individuals diagnosed with retinoblastoma (RB) exceed 95% in the United States; however, little is known about the long-term psychosocial outcomes of these survivors. PATIENTS AND METHODS: Adult RB survivors, diagnosed from 1932 to 1994 and treated in New York, completed a comprehensive questionnaire adapted from the Childhood Cancer Survivor Study (CCSS), by mail or telephone. Psychosocial outcomes included psychological distress, anxiety, depression, somatization, fear of cancer recurrence, satisfaction with facial appearance, post-traumatic growth, and post-traumatic stress symptoms; noncancer CCSS siblings served as a comparison group. RESULTS: A total of 470 RB survivors (53.6% with bilateral RB; 52.1% female) and 2,820 CCSS siblings were 43.3 (standard deviation [SD], 11) years and 33.2 (SD, 8.4) years old at the time of study, respectively. After adjusting for sociodemographic factors, RB survivors did not have significantly higher rates of depression, somatization, distress, or anxiety compared with CCSS siblings. Although RB survivors were more likely to report post-traumatic stress symptoms of avoidance and/or hyperarousal (both P < .01), only five (1.1%) of 470 met criteria for post-traumatic stress disorder. Among survivors, having a chronic medical condition did not increase the likelihood of psychological problems. Bilateral RB survivors were more likely than unilateral RB survivors to experience fears of cancer recurrence (P < .01) and worry about their children being diagnosed with RB (P < .01). However, bilateral RB survivors were no more likely to report depression, anxiety, or somatic complaints than unilateral survivors. CONCLUSION: Most RB survivors do not have poorer psychosocial functioning compared with a noncancer sample. In addition, bilateral and unilateral RB survivors seem similar with respect to their psychological symptoms.
Authors: Ruth A Kleinerman; Margaret A Tucker; David H Abramson; Johanna M Seddon; Robert E Tarone; Joseph F Fraumeni Journal: J Natl Cancer Inst Date: 2007-01-03 Impact factor: 13.506
Authors: Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2014-03-17 Impact factor: 44.544
Authors: Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: Med Pediatr Oncol Date: 2002-04
Authors: Brad J Zebrack; Lonnie K Zeltzer; John Whitton; Ann C Mertens; Lorrie Odom; Roger Berkow; Leslie L Robison Journal: Pediatrics Date: 2002-07 Impact factor: 9.703
Authors: Jennifer van Dijk; Jaap Huisman; Annette C Moll; Antoinette Y N Schouten-van Meeteren; Pieter D Bezemer; Peter J Ringens; Peggy T Cohen-Kettenis; Saskia M Imhof Journal: Health Qual Life Outcomes Date: 2007-12-03 Impact factor: 3.186
Authors: Smita C Banerjee; Elaine Pottenger; Mary Petriccione; Joanne F Chou; Jennifer S Ford; Charles A Sklar; Leslie L Robison; Ruth A Kleinerman; Kevin C Oeffinger; Jasmine H Francis; David H Abramson; Ira J Dunkel; Danielle Novetsky Friedman Journal: Palliat Support Care Date: 2020-06
Authors: Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Lee W Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Tara Sanft; Paula Silverman; Sophia Smith; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2016-06 Impact factor: 11.908
Authors: Danielle Novetsky Friedman; Joanne F Chou; Jasmine H Francis; Charles A Sklar; Yuelin Li; Mary McCabe; Leslie L Robison; Ruth A Kleinerman; Kevin C Oeffinger; David H Abramson; Ira J Dunkel; Jennifer S Ford Journal: JAMA Ophthalmol Date: 2018-06-01 Impact factor: 7.389
Authors: Victoria W Willard; Ibrahim Qaddoumi; Haitao Pan; Chia-Wei Hsu; Rachel C Brennan; Matthew W Wilson; Carlos Rodriguez-Galindo; Kristin Goode; Kendra Parris; Sean Phipps Journal: J Clin Oncol Date: 2021-04-23 Impact factor: 50.717
Authors: Nuray A McNeill; Wijnanda A Kors; Machteld I Bosscha; Jennifer van Dijk; Armida W M Fabius; Ton Houffelaar; Irma M Verdonck-de Leeuw; Annette C Moll Journal: J Cancer Surviv Date: 2017-09-25 Impact factor: 4.442
Authors: Kent W Mouw; Beow Y Yeap; Paul Caruso; Aaron Fay; Madhusmita Misra; Roshan V Sethi; Shannon M MacDonald; Yen-Lin Chen; Nancy J Tarbell; Torunn I Yock; Suzanne K Freitag; John E Munzenrider; Eric Grabowski; Michelle Katz; Karen Kuhlthau; Dawn DeCastro; Gena Heidary; Jessica Ciralsky; Shizuo Mukai; Helen A Shih Journal: Adv Radiat Oncol Date: 2017 Jan-Mar
Authors: Natalia Ziolkowski; Simon C Kitto; Dahn Jeong; Jennifer Zuccaro; Thomasin Adams-Webber; Anna Miroshnychenko; Joel S Fish Journal: BMJ Open Date: 2019-06-03 Impact factor: 2.692